For Hypertension, Entresto Expected as or More Effective than ARBs/ACE Inhibitors: Professor

October 21, 2021
Novartis Pharma’s heart failure drug Entresto (sacubitril valsartan sodium hydrate) is expected to be “as effective as or more effective than ARBs or ACE inhibitors” for the treatment of hypertension, a new indication granted late last month, a Japanese specialist...read more